A multicenter retrospective study on carcinoembryonic antigen (CEA) monitoring in post-surgical colorectal cancer patients included 1,832 stage II and III cancer patients, of whom 1,008 had complete follow-up data. The gene discussed is CEACAM5; the disease is cancer.